论文部分内容阅读
目的探讨左炔诺孕酮宫内缓释系统治疗子宫腺肌病的疗效。方法 2010年12月—2011年12月对30例子宫腺肌病患者采用放置左炔诺孕酮宫内缓释系统治疗,分别观察治疗前及治疗3、6、12个月后患者月经量、痛经、子宫体积及Hb变化情况。结果患者月经量评分、痛经评分、子宫体积治疗前及治疗12个月后分别为(100.0±0.0)分、(7.6±1.2)分、(157.8±75.6)cm3与(3.3±2.1)分、(1.4±0.5)分、(120.9±40.4)cm3、,差异均有统计学意义(均P<0.05)。结论子宫腺肌病可选用左炔诺孕酮宫内缓释系统治疗,效果好,安全且使用方便。
Objective To investigate the efficacy of levonorgestrel-releasing intrauterine system in the treatment of adenomyosis. Methods From December 2010 to December 2011, 30 cases of adenomyosis were treated with levonorgestrel-releasing intrauterine system, and the patients’ menstrual flow were observed before treatment and 3, 6 and 12 months after treatment, respectively. Dysmenorrhea, uterine volume and Hb changes. Results Menstrual score, dysmenorrhea score and uterine volume were (100.0 ± 0.0), (7.6 ± 1.2), (157.8 ± 75.6) cm3 and (3.3 ± 2.1) before and 12 months after treatment respectively 1.4 ± 0.5) points, (120.9 ± 40.4) cm3, the differences were statistically significant (P <0.05). Conclusions Levonorgestrel intrauterine sustained-release system is the best choice for treatment of adenomyosis, which is effective, safe and easy to use.